A phase I/II trial of CordIn along with a non-manipulated umbilical cord blood unit in a double graft configuration in patients with sickle cell disease

Trial Profile

A phase I/II trial of CordIn along with a non-manipulated umbilical cord blood unit in a double graft configuration in patients with sickle cell disease

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 16 Aug 2016

At a glance

  • Drugs Cord blood stem cell therapy (Primary)
  • Indications Sickle cell anaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 16 Aug 2016 New trial record
    • 27 Jul 2016 According to a Gamida-Cell media release, eight patients were transplanted in double graft configuration and preliminary data from this trial will be summarized and published later in 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top